Exploratory Trial of SAT-003 in Cancer Cachexia Patients With Discontinued Chemotherapy
NCT06476197
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Cancer Cachexia
Interventions
DEVICE:
SAT-003
Sponsor
S-Alpha Therapeutics, Inc.